Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Obesity mutes efficacy of sodium channel blockers for those with AFib

Atrial fibrillation patients who are obese are less likely to respond to sodium channel blockers than their normal-weight peers, according to a new study.

Thumbnail

Marijuana vapes can generate toxins when heated

Natural compounds mixed into THC vaping liquids could generate toxic chemicals when heated and inhaled, according to research out of Portland State University in Oregon.

Thumbnail

Cases of chronic HF expected to reach 32M by 2028

Diagnosed cases of chronic heart failure are expected to number 32 million by 2028, according to a report from analytics company GlobalData.

Preventive aspirin obsolete in light of improved access to statins, screenings

Updated screening technologies and more widespread use of statins have rendered aspirin ineffective for the primary prevention of CVD, according to a study published in Family Practice.

Thumbnail

‘Predatory targeting’: CDC finds 6M adolescents use tobacco

Results from the National Youth Tobacco Survey, released Dec. 5 by the CDC, reveal that 6.2 million middle- and high-school students have used a tobacco product in the past month.

Thumbnail

Prescribing OACs in the ED increases long-term use by 30%

Patients with atrial fibrillation may be more likely to stick to a regimen of oral anticoagulation if they’re first prescribed OACs in the emergency department, according to a study published Dec. 9 in the Canadian Medical Association Journal

Thumbnail

Vaping linked to clinical depression

Smoking e-cigarettes could have potentially deleterious effects on a person’s mental health, according to a JAMA Network Open study that solidified a link between vaping and self-reported clinical depression.

Thumbnail

Evolocumab plus high-intensity statin therapy effectively lowers LDL-C

A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.